"Executive Summary Infectious Disease Drug Market Size and Share Across Top Segments The global infectious disease drug market size was valued at USD 84.89 billion in 2024 and is expected to reach USD 129.79 billion by 2032, at a CAGR of 5.45% during the forecast period Infectious Disease Drug Market research report comprises of fundamental, secondary and...

"Executive Summary Uterine Polyps Drug Market Size and Share Across Top Segments The Global Uterine Polyps Drug Market size was valued at USD 1.2 billion in 2024 and is expected to reach USD 2.43 billion by 2032, at a CAGR of 9.2% during the forecast period Uterine Polyps Drug Market research report comprises of fundamental, secondary and advanced...

Executive Summary Addison's Disease Drug Market Size and Share Forecast Addison's Disease Drug Market Size The global Addison's Disease Drug Market was valued at USD 1.02 billion in 2024 and is expected to reach USD 1.96 billion by 2032. During the forecast period of 2025 to 2032, the market is projected to grow at a CAGR of 8.4%, primarily driven by increasing prevalence of...

Anal cancer, primarily squamous cell carcinoma, remains under-addressed compared to other cancers, yet its incidence is increasing due to HPV prevalence, HIV co-infection, and demographic shifts. The market encompasses medications such as chemotherapeutics, immunotherapies, and targeted agents used alone or in combination with surgery/radiation. Key growth stems from greater awareness,...

Biomimetic nanocarriers replicate natural biological components (e.g., cell membrane coatings, RBC-mimicking structures, platelet-inspired designs) to improve drug stability, targeted release, immune evasion, and site-specific delivery. They address limitations of traditional nanocarriers by enhancing biocompatibility and functionality. The market is driven by rising chronic disease burdens and...

The Global Drug Addiction Treatment Market is expanding significantly. Valued at USD 18.22 billion in 2024, the market is projected to reach USD 32.69 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.60% from 2025 to 2032. This article provides a comprehensive analysis of market dynamics, segmentation, drivers, challenges, and competitive landscape, drawing...

"Executive Summary Hyperoxaluria Drug Market: Share, Size & Strategic Insights The global hyperoxaluria drug market size was valued at USD 19.43 million in 2024 and is expected to reach USD 32.40 million by 2032, at a CAGR of 6.6% during the forecast period   To make better decisions, generate maximum revenue, and enhance business profit,...

Polaris Market Research has introduced the latest market research report titled AI In Drug Repurposing Market Size, Share, Trends, Industry Analysis Report By Drug Type, By Therapeutic Area, By Deployment Mode, By End User, By Region – Market Forecast, 2025–2034 that highlights the major revenue stream for the forecast period. The report contains clear, reliable, and...

The Small Molecule Cancer Drug market report is intended to function as a supportive means to assess the global Small Molecule Cancer Drug market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation....

"In-Depth Study on Executive Summary Irritable Bowel Syndrome (IBS) Market Size and Share The irritable bowel syndrome (IBS) market is expected to witness market growth at a rate of 12.90% in the forecast period of 2022 to 2029. As the high quality Irritable Bowel Syndrome (IBS) Market survey report has precise and accurate analysis of market trends, future developments, market...

"Key Drivers Impacting Executive Summary PEGylated Drugs Market Size and Share The global PEGylated drugs market size was valued at USD 16.01 billion in 2025 and is expected to reach USD 24.53 billion by 2033, at a CAGR of 5.48% during the forecast period The large-scale PEGylated Drugs Market report presents the best market and business solutions to...